Mortality as primary end point in studies of heparin thromboprophylaxis.
Locke
Charles F S
CF
D000925:Anticoagulants / Q000627:therapeutic use*; D006493:Heparin / Q000627:therapeutic use*; D006801:Humans; D017063:Outcome Assessment, Health Care; D011655:Pulmonary Embolism / Q000401:mortality / Q000517:prevention & control; D012107:Research Design; D016019:Survival Analysis; D013923:Thromboembolism / Q000401:mortality* / Q000517:prevention & control*; D020246:Venous Thrombosis / Q000401:mortality / Q000517:prevention & control
D000925:Anticoagulants; D006493:Heparin